We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Authors
Hollander, Priscilla A; Levy, Philip; Fineman, Mark S; Maggs, David G; Shen, Larry Z; Strobel, Susan A; Weyer, Christian; Kolterman, Orville G
- Abstract
Mealtime amylin replacement with the human amylin analog pramlintide, as an adjunct to mealtime insulin replacement, reduces postprandial glucose excursions in patients with type 2 diabetes. The aim of the present study was to assess the long-term efficacy and safety of pramlintide in this patient population.
- Publication
Diabetes care, 2003, Vol 26, Issue 3, p784
- ISSN
0149-5992
- Publication type
Journal Article
- DOI
10.2337/diacare.26.3.784